

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.95571619 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 6.95571619 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.70076593 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 6.70076593 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.49300113 |
| 6 | tryptophan catabolic process (GO:0006569) | 6.05620806 |
| 7 | indole-containing compound catabolic process (GO:0042436) | 6.05620806 |
| 8 | indolalkylamine catabolic process (GO:0046218) | 6.05620806 |
| 9 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.93763328 |
| 10 | kynurenine metabolic process (GO:0070189) | 5.80897867 |
| 11 | tryptophan metabolic process (GO:0006568) | 5.72418178 |
| 12 | glyoxylate metabolic process (GO:0046487) | 5.64213776 |
| 13 | bile acid biosynthetic process (GO:0006699) | 5.63978486 |
| 14 | alpha-linolenic acid metabolic process (GO:0036109) | 5.52613145 |
| 15 | urea metabolic process (GO:0019627) | 5.43115079 |
| 16 | urea cycle (GO:0000050) | 5.43115079 |
| 17 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.40437263 |
| 18 | protein carboxylation (GO:0018214) | 5.40437263 |
| 19 | high-density lipoprotein particle remodeling (GO:0034375) | 5.21248316 |
| 20 | cysteine metabolic process (GO:0006534) | 5.16338491 |
| 21 | negative regulation of fibrinolysis (GO:0051918) | 5.12001203 |
| 22 | complement activation, alternative pathway (GO:0006957) | 5.08772945 |
| 23 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.04991933 |
| 24 | sulfur amino acid catabolic process (GO:0000098) | 5.00560099 |
| 25 | regulation of protein activation cascade (GO:2000257) | 5.00428066 |
| 26 | nitrogen cycle metabolic process (GO:0071941) | 4.99293848 |
| 27 | regulation of fibrinolysis (GO:0051917) | 4.85874672 |
| 28 | serine family amino acid catabolic process (GO:0009071) | 4.81992722 |
| 29 | bile acid metabolic process (GO:0008206) | 4.75582271 |
| 30 | lysine catabolic process (GO:0006554) | 4.73754318 |
| 31 | lysine metabolic process (GO:0006553) | 4.73754318 |
| 32 | homocysteine metabolic process (GO:0050667) | 4.73539394 |
| 33 | aromatic amino acid family metabolic process (GO:0009072) | 4.73368868 |
| 34 | regulation of complement activation (GO:0030449) | 4.70383270 |
| 35 | regulation of triglyceride catabolic process (GO:0010896) | 4.63024705 |
| 36 | amino-acid betaine metabolic process (GO:0006577) | 4.59273497 |
| 37 | protein-lipid complex remodeling (GO:0034368) | 4.55018323 |
| 38 | macromolecular complex remodeling (GO:0034367) | 4.55018323 |
| 39 | plasma lipoprotein particle remodeling (GO:0034369) | 4.55018323 |
| 40 | regulation of cholesterol esterification (GO:0010872) | 4.54868952 |
| 41 | reverse cholesterol transport (GO:0043691) | 4.53373512 |
| 42 | tyrosine metabolic process (GO:0006570) | 4.47173497 |
| 43 | alpha-amino acid catabolic process (GO:1901606) | 4.43000849 |
| 44 | phospholipid efflux (GO:0033700) | 4.32863908 |
| 45 | imidazole-containing compound metabolic process (GO:0052803) | 4.32400890 |
| 46 | glycine metabolic process (GO:0006544) | 4.30833865 |
| 47 | acylglycerol homeostasis (GO:0055090) | 4.30828805 |
| 48 | triglyceride homeostasis (GO:0070328) | 4.30828805 |
| 49 | indolalkylamine metabolic process (GO:0006586) | 4.29377649 |
| 50 | plasma lipoprotein particle clearance (GO:0034381) | 4.29011611 |
| 51 | cellular ketone body metabolic process (GO:0046950) | 4.27974354 |
| 52 | amine catabolic process (GO:0009310) | 4.25664430 |
| 53 | cellular biogenic amine catabolic process (GO:0042402) | 4.25664430 |
| 54 | ethanol oxidation (GO:0006069) | 4.23594629 |
| 55 | aldehyde catabolic process (GO:0046185) | 4.22592538 |
| 56 | bile acid and bile salt transport (GO:0015721) | 4.21245396 |
| 57 | negative regulation of sterol transport (GO:0032372) | 4.16128556 |
| 58 | negative regulation of cholesterol transport (GO:0032375) | 4.16128556 |
| 59 | cellular glucuronidation (GO:0052695) | 4.12560828 |
| 60 | cellular amino acid catabolic process (GO:0009063) | 4.05545161 |
| 61 | serine family amino acid metabolic process (GO:0009069) | 4.04033963 |
| 62 | benzene-containing compound metabolic process (GO:0042537) | 4.02243889 |
| 63 | low-density lipoprotein particle remodeling (GO:0034374) | 4.01593839 |
| 64 | coenzyme catabolic process (GO:0009109) | 4.01108351 |
| 65 | cholesterol efflux (GO:0033344) | 3.98367496 |
| 66 | fibrinolysis (GO:0042730) | 3.87749753 |
| 67 | plasma lipoprotein particle assembly (GO:0034377) | 3.84808653 |
| 68 | serine family amino acid biosynthetic process (GO:0009070) | 3.84574819 |
| 69 | cellular response to ATP (GO:0071318) | 3.78437289 |
| 70 | arginine metabolic process (GO:0006525) | 3.77391239 |
| 71 | cellular modified amino acid catabolic process (GO:0042219) | 3.73785501 |
| 72 | glutamate metabolic process (GO:0006536) | 3.72993396 |
| 73 | uronic acid metabolic process (GO:0006063) | 3.71586432 |
| 74 | glucuronate metabolic process (GO:0019585) | 3.71586432 |
| 75 | regulation of skeletal muscle contraction (GO:0014819) | 3.71508693 |
| 76 | ketone body metabolic process (GO:1902224) | 3.69316516 |
| 77 | cofactor catabolic process (GO:0051187) | 3.68899548 |
| 78 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.68028076 |
| 79 | NAD biosynthetic process (GO:0009435) | 3.67971961 |
| 80 | drug catabolic process (GO:0042737) | 3.67146764 |
| 81 | blood coagulation, intrinsic pathway (GO:0007597) | 3.65433375 |
| 82 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.65253116 |
| 83 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.65253116 |
| 84 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.64024744 |
| 85 | carboxylic acid catabolic process (GO:0046395) | 3.62859772 |
| 86 | organic acid catabolic process (GO:0016054) | 3.62859772 |
| 87 | phospholipid homeostasis (GO:0055091) | 3.62308923 |
| 88 | 2-oxoglutarate metabolic process (GO:0006103) | 3.60265572 |
| 89 | positive regulation of lipid catabolic process (GO:0050996) | 3.57371611 |
| 90 | protein activation cascade (GO:0072376) | 3.55356278 |
| 91 | neutrophil activation involved in immune response (GO:0002283) | 3.54633656 |
| 92 | plasma lipoprotein particle organization (GO:0071827) | 3.54178210 |
| 93 | short-chain fatty acid metabolic process (GO:0046459) | 3.53453504 |
| 94 | complement activation (GO:0006956) | 3.52986025 |
| 95 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.52860987 |
| 96 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.52860987 |
| 97 | carnitine metabolic process (GO:0009437) | 3.52536251 |
| 98 | complement activation, classical pathway (GO:0006958) | 3.51687055 |
| 99 | cholesterol homeostasis (GO:0042632) | 3.50928568 |
| 100 | response to nitrosative stress (GO:0051409) | 3.48754481 |
| 101 | acetyl-CoA metabolic process (GO:0006084) | 3.48533284 |
| 102 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 3.46937954 |
| 103 | sterol homeostasis (GO:0055092) | 3.46018183 |
| 104 | fatty acid beta-oxidation (GO:0006635) | 3.43102498 |
| 105 | adenosine receptor signaling pathway (GO:0001973) | 3.31873028 |
| 106 | respiratory chain complex IV assembly (GO:0008535) | 3.29129594 |
| 107 | GDP-mannose metabolic process (GO:0019673) | 3.20971763 |
| 108 | rRNA methylation (GO:0031167) | 3.11160997 |
| 109 | rRNA modification (GO:0000154) | 2.95051771 |
| 110 | cytochrome complex assembly (GO:0017004) | 2.92052852 |
| 111 | leukocyte degranulation (GO:0043299) | 2.83441344 |
| 112 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.82249516 |
| 113 | NADH dehydrogenase complex assembly (GO:0010257) | 2.82249516 |
| 114 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.82249516 |
| 115 | DNA deamination (GO:0045006) | 2.79741640 |
| 116 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.76862836 |
| 117 | detection of light stimulus involved in visual perception (GO:0050908) | 2.76862836 |
| 118 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.75962416 |
| 119 | response to ATP (GO:0033198) | 2.73732453 |
| 120 | purinergic receptor signaling pathway (GO:0035587) | 2.72258905 |
| 121 | response to peptidoglycan (GO:0032494) | 2.71935419 |
| 122 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.71919171 |
| 123 | cardiolipin metabolic process (GO:0032048) | 2.69558367 |
| 124 | pyridine-containing compound biosynthetic process (GO:0072525) | 2.68987021 |
| 125 | pseudouridine synthesis (GO:0001522) | 2.68908500 |
| 126 | amino acid salvage (GO:0043102) | 2.68776320 |
| 127 | L-methionine salvage (GO:0071267) | 2.68776320 |
| 128 | L-methionine biosynthetic process (GO:0071265) | 2.68776320 |
| 129 | positive regulation of heat generation (GO:0031652) | 2.63088200 |
| 130 | proteasome assembly (GO:0043248) | 2.63047094 |
| 131 | methionine biosynthetic process (GO:0009086) | 2.60019461 |
| 132 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.56078285 |
| 133 | behavioral response to nicotine (GO:0035095) | 2.55806065 |
| 134 | DNA replication checkpoint (GO:0000076) | 2.54472646 |
| 135 | detection of molecule of bacterial origin (GO:0032490) | 2.50181035 |
| 136 | regulation of mast cell activation (GO:0033003) | 2.49956484 |
| 137 | regulation of memory T cell differentiation (GO:0043380) | 2.47535145 |
| 138 | granulocyte activation (GO:0036230) | 2.47245302 |
| 139 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.46819696 |
| 140 | ATP synthesis coupled proton transport (GO:0015986) | 2.45565416 |
| 141 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.45565416 |
| 142 | protein complex biogenesis (GO:0070271) | 2.44917944 |
| 143 | superoxide anion generation (GO:0042554) | 2.44098445 |
| 144 | positive regulation of mast cell activation (GO:0033005) | 2.41997804 |
| 145 | negative regulation of interleukin-12 production (GO:0032695) | 2.41718424 |
| 146 | heme transport (GO:0015886) | 2.41453106 |
| 147 | response to interferon-beta (GO:0035456) | 2.40610540 |
| 148 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.40166545 |
| 149 | termination of RNA polymerase III transcription (GO:0006386) | 2.40166545 |
| 150 | neutrophil activation (GO:0042119) | 2.36219989 |
| 151 | peptidyl-histidine modification (GO:0018202) | 2.36122452 |
| 152 | S-adenosylmethionine metabolic process (GO:0046500) | 2.35074925 |
| 153 | myeloid cell activation involved in immune response (GO:0002275) | 2.34825210 |
| 154 | indole-containing compound metabolic process (GO:0042430) | 2.32870505 |
| 155 | dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 2.32867098 |
| 156 | electron transport chain (GO:0022900) | 2.32596658 |
| 157 | NAD metabolic process (GO:0019674) | 2.31102152 |
| 158 | negative regulation of interleukin-1 production (GO:0032692) | 2.30892206 |
| 159 | methionine metabolic process (GO:0006555) | 2.30477201 |
| 160 | endosome to pigment granule transport (GO:0043485) | 2.30238573 |
| 161 | endosome to melanosome transport (GO:0035646) | 2.30238573 |
| 162 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.29244298 |
| 163 | pantothenate metabolic process (GO:0015939) | 2.28798361 |
| 164 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.28754717 |
| 165 | respiratory electron transport chain (GO:0022904) | 2.28544989 |
| 166 | meiotic chromosome segregation (GO:0045132) | 2.28372105 |
| 167 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.28295602 |
| 168 | sulfation (GO:0051923) | 2.27499090 |
| 169 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.26977203 |
| 170 | negative regulation of tumor necrosis factor production (GO:0032720) | 2.26233214 |
| 171 | response to misfolded protein (GO:0051788) | 2.24987140 |
| 172 | autophagic vacuole fusion (GO:0000046) | 2.24412075 |
| 173 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.24155743 |
| 174 | low-density lipoprotein particle clearance (GO:0034383) | 2.22764202 |
| 175 | oligosaccharide catabolic process (GO:0009313) | 2.21814243 |
| 176 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.21278896 |
| 177 | regulation of mast cell degranulation (GO:0043304) | 2.20736425 |
| 178 | protein neddylation (GO:0045116) | 2.20688111 |
| 179 | negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556) | 2.17862490 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.72962012 |
| 2 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.74917519 |
| 3 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.73245260 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.93379097 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.10016580 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.04214932 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.67165674 |
| 8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.97347300 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.54628789 |
| 10 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.64072067 |
| 11 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.55662226 |
| 12 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.29534059 |
| 13 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.25425377 |
| 14 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.24223905 |
| 15 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.18850034 |
| 16 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.02964349 |
| 17 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 2.02325404 |
| 18 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.0379158 |
| 19 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.94538505 |
| 20 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.91967455 |
| 21 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.87721053 |
| 22 | GATA1_22025678_ChIP-Seq_K562_Human | 1.86630381 |
| 23 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.84313481 |
| 24 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.84018711 |
| 25 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.83851377 |
| 26 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.75368105 |
| 27 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.73306567 |
| 28 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.72651284 |
| 29 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.70994474 |
| 30 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.67379632 |
| 31 | * P68_20966046_ChIP-Seq_HELA_Human | 1.65833878 |
| 32 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.65619350 |
| 33 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.63873141 |
| 34 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.59707764 |
| 35 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.54211350 |
| 36 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.53484619 |
| 37 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.51664950 |
| 38 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.51139061 |
| 39 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.50896409 |
| 40 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.49840474 |
| 41 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.49156948 |
| 42 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.47084843 |
| 43 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.45587564 |
| 44 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.45548837 |
| 45 | VDR_22108803_ChIP-Seq_LS180_Human | 1.45029386 |
| 46 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.44820050 |
| 47 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.44300869 |
| 48 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.43804740 |
| 49 | SPI1_23127762_ChIP-Seq_K562_Human | 1.42053937 |
| 50 | MAF_26560356_Chip-Seq_TH2_Human | 1.41823582 |
| 51 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.39776177 |
| 52 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.39006492 |
| 53 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.37859315 |
| 54 | ERA_21632823_ChIP-Seq_H3396_Human | 1.37804308 |
| 55 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.37746531 |
| 56 | * GATA1_19941826_ChIP-Seq_K562_Human | 1.37361376 |
| 57 | * NANOG_20526341_ChIP-Seq_ESCs_Human | 1.34233725 |
| 58 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.34209090 |
| 59 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.34128952 |
| 60 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.34043065 |
| 61 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.31514617 |
| 62 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.31148278 |
| 63 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.30353327 |
| 64 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.30222049 |
| 65 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.29754987 |
| 66 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.27953544 |
| 67 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.27450444 |
| 68 | MAF_26560356_Chip-Seq_TH1_Human | 1.26582141 |
| 69 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.26553960 |
| 70 | P300_27268052_Chip-Seq_Bcells_Human | 1.26019183 |
| 71 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.25297092 |
| 72 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.22007347 |
| 73 | P53_21459846_ChIP-Seq_SAOS-2_Human | 1.20565146 |
| 74 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.19978230 |
| 75 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.19803605 |
| 76 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.19677478 |
| 77 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.19080975 |
| 78 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.18730559 |
| 79 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.17725780 |
| 80 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.17420266 |
| 81 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.16902578 |
| 82 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.14845758 |
| 83 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.14804499 |
| 84 | SA1_27219007_Chip-Seq_Bcells_Human | 1.14798958 |
| 85 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.14769219 |
| 86 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13523102 |
| 87 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.13461217 |
| 88 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.13109470 |
| 89 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.12686159 |
| 90 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.12269246 |
| 91 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.11087522 |
| 92 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.10767225 |
| 93 | GATA3_26560356_Chip-Seq_TH2_Human | 1.10121118 |
| 94 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.09919548 |
| 95 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.09835259 |
| 96 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.07306393 |
| 97 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.06885043 |
| 98 | * CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.06787774 |
| 99 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.06591997 |
| 100 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05667889 |
| 101 | UTX_26944678_Chip-Seq_JUKART_Human | 1.05169247 |
| 102 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.04536200 |
| 103 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.02041670 |
| 104 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.01215922 |
| 105 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.99397567 |
| 106 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.99339898 |
| 107 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.98979071 |
| 108 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.97091696 |
| 109 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.93296895 |
| 110 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.86845130 |
| 111 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.85926771 |
| 112 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.85083052 |
| 113 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.84501323 |
| 114 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.84426426 |
| 115 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.83754964 |
| 116 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.83495286 |
| 117 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.82455522 |
| 118 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.78311862 |
| 119 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.72663483 |
| 120 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.72663483 |
| 121 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.71409088 |
| 122 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.70399258 |
| 123 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.70019887 |
| 124 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.68716351 |
| 125 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.67689075 |
| 126 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.65869306 |
| 127 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.64896050 |
| 128 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.64695415 |
| 129 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.64643322 |
| 130 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.64417754 |
| 131 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.64175652 |
| 132 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.64098888 |
| 133 | AR_20517297_ChIP-Seq_VCAP_Human | 0.61614136 |
| 134 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.60964330 |
| 135 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.60165459 |
| 136 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.58786242 |
| 137 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.58430426 |
| 138 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.58205435 |
| 139 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.58160283 |
| 140 | * CEBPB_22108803_ChIP-Seq_LS180_Human | 0.55399217 |
| 141 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.55049219 |
| 142 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.54975126 |
| 143 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.54480078 |
| 144 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.54163754 |
| 145 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.54103788 |
| 146 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.53877824 |
| 147 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.53617691 |
| 148 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.53356129 |
| 149 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.52617563 |
| 150 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.52616726 |
| 151 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.51805117 |
| 152 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.51685436 |
| 153 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.51317118 |
| 154 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.50489926 |
| 155 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.50367039 |
| 156 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.50216523 |
| 157 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.48974521 |
| 158 | * RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.48839862 |
| 159 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.48212147 |
| 160 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.48046880 |
| 161 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.46941248 |
| 162 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.46651534 |
| 163 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.46451230 |
| 164 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.45588221 |
| 165 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.43693971 |
| 166 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.42923633 |
| 167 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.42442925 |
| 168 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.42213567 |
| 169 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.41833443 |
| 170 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.41347482 |
| 171 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.40425097 |
| 172 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.39663196 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.79658923 |
| 2 | MP0005360_urolithiasis | 7.00379838 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.96040194 |
| 4 | MP0005365_abnormal_bile_salt | 5.70421381 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.67149847 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.20964398 |
| 7 | MP0003252_abnormal_bile_duct | 3.63841637 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.33792243 |
| 9 | MP0003136_yellow_coat_color | 3.27344446 |
| 10 | MP0005083_abnormal_biliary_tract | 3.11229828 |
| 11 | MP0009840_abnormal_foam_cell | 2.97897217 |
| 12 | MP0005171_absent_coat_pigmentation | 2.86836206 |
| 13 | MP0005174_abnormal_tail_pigmentation | 2.85982186 |
| 14 | MP0001986_abnormal_taste_sensitivity | 2.64128845 |
| 15 | MP0005332_abnormal_amino_acid | 2.63261163 |
| 16 | MP0003195_calcinosis | 2.62459540 |
| 17 | MP0001666_abnormal_nutrient_absorption | 2.37076670 |
| 18 | MP0004147_increased_porphyrin_level | 2.35247418 |
| 19 | MP0003191_abnormal_cellular_cholesterol | 2.32765127 |
| 20 | MP0001968_abnormal_touch/_nociception | 2.25486464 |
| 21 | MP0003646_muscle_fatigue | 2.20371240 |
| 22 | MP0000609_abnormal_liver_physiology | 2.12253004 |
| 23 | MP0002736_abnormal_nociception_after | 2.10919139 |
| 24 | MP0009697_abnormal_copulation | 2.01909545 |
| 25 | MP0004019_abnormal_vitamin_homeostasis | 1.98244683 |
| 26 | MP0002138_abnormal_hepatobiliary_system | 1.97147296 |
| 27 | MP0005319_abnormal_enzyme/_coenzyme | 1.95692215 |
| 28 | MP0002118_abnormal_lipid_homeostasis | 1.92436301 |
| 29 | MP0002148_abnormal_hypersensitivity_rea | 1.90916795 |
| 30 | MP0001764_abnormal_homeostasis | 1.79167258 |
| 31 | MP0003186_abnormal_redox_activity | 1.76398753 |
| 32 | MP0003868_abnormal_feces_composition | 1.70768472 |
| 33 | MP0000015_abnormal_ear_pigmentation | 1.68533715 |
| 34 | * MP0005584_abnormal_enzyme/coenzyme_acti | 1.50000297 |
| 35 | MP0005167_abnormal_blood-brain_barrier | 1.47754861 |
| 36 | MP0003656_abnormal_erythrocyte_physiolo | 1.46260529 |
| 37 | MP0009764_decreased_sensitivity_to | 1.39842719 |
| 38 | MP0003303_peritoneal_inflammation | 1.32583967 |
| 39 | MP0009643_abnormal_urine_homeostasis | 1.31692052 |
| 40 | MP0005410_abnormal_fertilization | 1.29525594 |
| 41 | MP0005423_abnormal_somatic_nervous | 1.25255474 |
| 42 | MP0000598_abnormal_liver_morphology | 1.25183415 |
| 43 | MP0005671_abnormal_response_to | 1.23040431 |
| 44 | MP0005397_hematopoietic_system_phenotyp | 1.22731086 |
| 45 | MP0001545_abnormal_hematopoietic_system | 1.22731086 |
| 46 | MP0005451_abnormal_body_composition | 1.22012516 |
| 47 | MP0005551_abnormal_eye_electrophysiolog | 1.21320752 |
| 48 | MP0004043_abnormal_pH_regulation | 1.20575071 |
| 49 | MP0003705_abnormal_hypodermis_morpholog | 1.20000586 |
| 50 | MP0003011_delayed_dark_adaptation | 1.19959322 |
| 51 | MP0000372_irregular_coat_pigmentation | 1.18071716 |
| 52 | MP0009278_abnormal_bone_marrow | 1.17213034 |
| 53 | MP0008872_abnormal_physiological_respon | 1.16880890 |
| 54 | MP0002723_abnormal_immune_serum | 1.16276893 |
| 55 | MP0008469_abnormal_protein_level | 1.15957730 |
| 56 | MP0009763_increased_sensitivity_to | 1.15808591 |
| 57 | MP0004381_abnormal_hair_follicle | 1.14101461 |
| 58 | MP0003436_decreased_susceptibility_to | 1.12815506 |
| 59 | MP0005647_abnormal_sex_gland | 1.10068141 |
| 60 | MP0002452_abnormal_antigen_presenting | 1.07428783 |
| 61 | MP0003878_abnormal_ear_physiology | 1.06861113 |
| 62 | MP0005377_hearing/vestibular/ear_phenot | 1.06861113 |
| 63 | MP0003879_abnormal_hair_cell | 1.06319995 |
| 64 | MP0003724_increased_susceptibility_to | 1.05421298 |
| 65 | MP0006036_abnormal_mitochondrial_physio | 1.03646561 |
| 66 | MP0002332_abnormal_exercise_endurance | 1.01813673 |
| 67 | MP0004510_myositis | 1.00838124 |
| 68 | MP0010368_abnormal_lymphatic_system | 1.00299097 |
| 69 | MP0005000_abnormal_immune_tolerance | 0.98852992 |
| 70 | MP0001800_abnormal_humoral_immune | 0.96989574 |
| 71 | MP0009046_muscle_twitch | 0.95169443 |
| 72 | MP0001501_abnormal_sleep_pattern | 0.93829186 |
| 73 | MP0005464_abnormal_platelet_physiology | 0.93317271 |
| 74 | MP0005636_abnormal_mineral_homeostasis | 0.92822777 |
| 75 | MP0005408_hypopigmentation | 0.92724069 |
| 76 | MP0001819_abnormal_immune_cell | 0.91208385 |
| 77 | MP0000371_diluted_coat_color | 0.91008445 |
| 78 | MP0002420_abnormal_adaptive_immunity | 0.89404551 |
| 79 | MP0000358_abnormal_cell_content/ | 0.88613380 |
| 80 | MP0009642_abnormal_blood_homeostasis | 0.88168317 |
| 81 | MP0005058_abnormal_lysosome_morphology | 0.86991061 |
| 82 | MP0000604_amyloidosis | 0.86763947 |
| 83 | MP0009333_abnormal_splenocyte_physiolog | 0.86142968 |
| 84 | MP0003137_abnormal_impulse_conducting | 0.85147064 |
| 85 | MP0005376_homeostasis/metabolism_phenot | 0.84088624 |
| 86 | MP0005387_immune_system_phenotype | 0.83567222 |
| 87 | MP0001790_abnormal_immune_system | 0.83567222 |
| 88 | MP0002638_abnormal_pupillary_reflex | 0.81937415 |
| 89 | MP0000750_abnormal_muscle_regeneration | 0.81463272 |
| 90 | MP0002254_reproductive_system_inflammat | 0.78447484 |
| 91 | MP0009785_altered_susceptibility_to | 0.78279854 |
| 92 | MP0002876_abnormal_thyroid_physiology | 0.77549326 |
| 93 | MP0001853_heart_inflammation | 0.77181538 |
| 94 | MP0000569_abnormal_digit_pigmentation | 0.77058224 |
| 95 | MP0000689_abnormal_spleen_morphology | 0.77010523 |
| 96 | MP0005670_abnormal_white_adipose | 0.76710376 |
| 97 | MP0000230_abnormal_systemic_arterial | 0.76361562 |
| 98 | MP0004782_abnormal_surfactant_physiolog | 0.76327598 |
| 99 | MP0002064_seizures | 0.76206218 |
| 100 | MP0001970_abnormal_pain_threshold | 0.75475614 |
| 101 | MP0004142_abnormal_muscle_tone | 0.75455945 |
| 102 | MP0004130_abnormal_muscle_cell | 0.75445294 |
| 103 | MP0009765_abnormal_xenobiotic_induced | 0.73504330 |
| 104 | MP0005084_abnormal_gallbladder_morpholo | 0.73403059 |
| 105 | MP0002078_abnormal_glucose_homeostasis | 0.70928819 |
| 106 | MP0005334_abnormal_fat_pad | 0.70322070 |
| 107 | MP0005220_abnormal_exocrine_pancreas | 0.68905906 |
| 108 | MP0002419_abnormal_innate_immunity | 0.67826765 |
| 109 | MP0001756_abnormal_urination | 0.67674632 |
| 110 | MP0005266_abnormal_metabolism | 0.67527069 |
| 111 | MP0002971_abnormal_brown_adipose | 0.67020593 |
| 112 | MP0001835_abnormal_antigen_presentation | 0.65122878 |
| 113 | MP0001845_abnormal_inflammatory_respons | 0.63178759 |
| 114 | MP0006035_abnormal_mitochondrial_morpho | 0.63087956 |
| 115 | MP0001661_extended_life_span | 0.62319919 |
| 116 | MP0005025_abnormal_response_to | 0.60363163 |
| 117 | MP0006082_CNS_inflammation | 0.56289444 |
| 118 | MP0002136_abnormal_kidney_physiology | 0.56255654 |
| 119 | MP0009053_abnormal_anal_canal | 0.55728165 |
| 120 | MP0003690_abnormal_glial_cell | 0.54982215 |
| 121 | MP0005535_abnormal_body_temperature | 0.54688987 |
| 122 | MP0008873_increased_physiological_sensi | 0.52444435 |
| 123 | MP0003300_gastrointestinal_ulcer | 0.49683389 |
| 124 | MP0000249_abnormal_blood_vessel | 0.49352588 |
| 125 | MP0005166_decreased_susceptibility_to | 0.48454282 |
| 126 | MP0002132_abnormal_respiratory_system | 0.47680343 |
| 127 | MP0005395_other_phenotype | 0.46342235 |
| 128 | MP0001533_abnormal_skeleton_physiology | 0.46130512 |
| 129 | MP0003638_abnormal_response/metabolism_ | 0.44038425 |
| 130 | MP0000639_abnormal_adrenal_gland | 0.43859301 |
| 131 | MP0005448_abnormal_energy_balance | 0.43725748 |
| 132 | MP0002928_abnormal_bile_duct | 0.43706906 |
| 133 | MP0009115_abnormal_fat_cell | 0.43066940 |
| 134 | MP0003075_altered_response_to | 0.41504674 |
| 135 | MP0001881_abnormal_mammary_gland | 0.38608589 |
| 136 | MP0003172_abnormal_lysosome_physiology | 0.38120466 |
| 137 | MP0003718_maternal_effect | 0.37667253 |
| 138 | MP0008874_decreased_physiological_sensi | 0.37287912 |
| 139 | MP0004883_abnormal_blood_vessel | 0.36595592 |
| 140 | MP0000343_altered_response_to | 0.36539259 |
| 141 | MP0002168_other_aberrant_phenotype | 0.36399296 |
| 142 | MP0001243_abnormal_dermal_layer | 0.36094845 |
| 143 | MP0005164_abnormal_response_to | 0.36025845 |
| 144 | MP0010155_abnormal_intestine_physiology | 0.35577049 |
| 145 | MP0005666_abnormal_adipose_tissue | 0.35268095 |
| 146 | MP0000685_abnormal_immune_system | 0.35087829 |
| 147 | MP0005023_abnormal_wound_healing | 0.34716122 |
| 148 | MP0002970_abnormal_white_adipose | 0.34321715 |
| 149 | MP0002837_dystrophic_cardiac_calcinosis | 0.33562757 |
| 150 | MP0002135_abnormal_kidney_morphology | 0.32810073 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.75590368 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 6.73258669 |
| 3 | Deep venous thrombosis (HP:0002625) | 6.59217488 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.21007215 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 6.17555034 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 5.99142118 |
| 7 | Xanthomatosis (HP:0000991) | 5.64384751 |
| 8 | Joint hemorrhage (HP:0005261) | 4.94063236 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 4.94046189 |
| 10 | Complement deficiency (HP:0004431) | 4.88111587 |
| 11 | Hyperammonemia (HP:0001987) | 4.46388173 |
| 12 | Hypolipoproteinemia (HP:0010981) | 4.46229407 |
| 13 | Abnormality of the common coagulation pathway (HP:0010990) | 4.36293630 |
| 14 | Hyperglycinemia (HP:0002154) | 4.12818914 |
| 15 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.12607015 |
| 16 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.10198726 |
| 17 | Epidermoid cyst (HP:0200040) | 4.08223499 |
| 18 | Abnormality of methionine metabolism (HP:0010901) | 4.06646678 |
| 19 | Ketosis (HP:0001946) | 3.99456155 |
| 20 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.97630375 |
| 21 | Hypoglycemic coma (HP:0001325) | 3.95527937 |
| 22 | Fat malabsorption (HP:0002630) | 3.91967341 |
| 23 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.90595338 |
| 24 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.87728618 |
| 25 | Hyperglycinuria (HP:0003108) | 3.87413946 |
| 26 | Abnormality of the intrinsic pathway (HP:0010989) | 3.86979860 |
| 27 | Hypoalphalipoproteinemia (HP:0003233) | 3.82113811 |
| 28 | Abnormality of glycine metabolism (HP:0010895) | 3.75288936 |
| 29 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.75288936 |
| 30 | Abnormality of complement system (HP:0005339) | 3.71332553 |
| 31 | Congenital stationary night blindness (HP:0007642) | 3.67243955 |
| 32 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.59299949 |
| 33 | Abnormality of alanine metabolism (HP:0010916) | 3.58998017 |
| 34 | Hyperalaninemia (HP:0003348) | 3.58998017 |
| 35 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 3.58998017 |
| 36 | Conjugated hyperbilirubinemia (HP:0002908) | 3.54905195 |
| 37 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.47516856 |
| 38 | Hypercholesterolemia (HP:0003124) | 3.45131879 |
| 39 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.44842041 |
| 40 | Attenuation of retinal blood vessels (HP:0007843) | 3.42792900 |
| 41 | Increased cerebral lipofuscin (HP:0011813) | 3.36458029 |
| 42 | Hyperbilirubinemia (HP:0002904) | 3.32231318 |
| 43 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 3.16604170 |
| 44 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.15396270 |
| 45 | Systemic lupus erythematosus (HP:0002725) | 3.10944239 |
| 46 | Abnormality of nucleobase metabolism (HP:0010932) | 3.07283763 |
| 47 | Steatorrhea (HP:0002570) | 3.02880951 |
| 48 | Abnormality of serum amino acid levels (HP:0003112) | 3.01855237 |
| 49 | Ketoacidosis (HP:0001993) | 2.94832393 |
| 50 | Myocardial infarction (HP:0001658) | 2.92453726 |
| 51 | Hepatocellular carcinoma (HP:0001402) | 2.87500268 |
| 52 | Petechiae (HP:0000967) | 2.87106682 |
| 53 | Delayed CNS myelination (HP:0002188) | 2.87079945 |
| 54 | Dyschromatopsia (HP:0007641) | 2.84755800 |
| 55 | Facial diplegia (HP:0001349) | 2.83670575 |
| 56 | Dicarboxylic aciduria (HP:0003215) | 2.82275364 |
| 57 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.82275364 |
| 58 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.80696161 |
| 59 | Hypochromic microcytic anemia (HP:0004840) | 2.78585960 |
| 60 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.76856221 |
| 61 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.76856221 |
| 62 | Abnormality of glycolipid metabolism (HP:0010969) | 2.76856221 |
| 63 | Metabolic acidosis (HP:0001942) | 2.75439565 |
| 64 | Renal Fanconi syndrome (HP:0001994) | 2.71591830 |
| 65 | Decreased central vision (HP:0007663) | 2.67797632 |
| 66 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.67196442 |
| 67 | Abnormality of purine metabolism (HP:0004352) | 2.67061336 |
| 68 | Stomatitis (HP:0010280) | 2.66818625 |
| 69 | Glomerulonephritis (HP:0000099) | 2.65931529 |
| 70 | Skin nodule (HP:0200036) | 2.65838322 |
| 71 | Increased CSF lactate (HP:0002490) | 2.65160797 |
| 72 | Birth length less than 3rd percentile (HP:0003561) | 2.62786909 |
| 73 | Type I transferrin isoform profile (HP:0003642) | 2.61972913 |
| 74 | Lethargy (HP:0001254) | 2.60044059 |
| 75 | Mitochondrial inheritance (HP:0001427) | 2.56210092 |
| 76 | Lipid accumulation in hepatocytes (HP:0006561) | 2.54302404 |
| 77 | Cerebral edema (HP:0002181) | 2.50556953 |
| 78 | Vascular calcification (HP:0004934) | 2.48404019 |
| 79 | Acute encephalopathy (HP:0006846) | 2.42902025 |
| 80 | Generalized aminoaciduria (HP:0002909) | 2.42872245 |
| 81 | Acute necrotizing encephalopathy (HP:0006965) | 2.42490571 |
| 82 | Testicular atrophy (HP:0000029) | 2.39079025 |
| 83 | Acanthocytosis (HP:0001927) | 2.38494148 |
| 84 | Anorexia (HP:0002039) | 2.37649807 |
| 85 | Spontaneous abortion (HP:0005268) | 2.37205681 |
| 86 | Increased hepatocellular lipid droplets (HP:0006565) | 2.35775751 |
| 87 | Mitral stenosis (HP:0001718) | 2.35653108 |
| 88 | Hepatocellular necrosis (HP:0001404) | 2.35628335 |
| 89 | Spastic diplegia (HP:0001264) | 2.34170918 |
| 90 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.34043484 |
| 91 | Prolonged bleeding time (HP:0003010) | 2.33797973 |
| 92 | Vacuolated lymphocytes (HP:0001922) | 2.32504372 |
| 93 | Gingival bleeding (HP:0000225) | 2.31995758 |
| 94 | Renal cortical cysts (HP:0000803) | 2.31785903 |
| 95 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.29624626 |
| 96 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.29262546 |
| 97 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.29262546 |
| 98 | Abnormal protein glycosylation (HP:0012346) | 2.29262546 |
| 99 | Abnormal glycosylation (HP:0012345) | 2.29262546 |
| 100 | Orchitis (HP:0100796) | 2.28566358 |
| 101 | Menorrhagia (HP:0000132) | 2.27602030 |
| 102 | Hepatic necrosis (HP:0002605) | 2.27079259 |
| 103 | Esophageal varix (HP:0002040) | 2.26754801 |
| 104 | Myositis (HP:0100614) | 2.26622234 |
| 105 | Nausea (HP:0002018) | 2.26264620 |
| 106 | Increased muscle lipid content (HP:0009058) | 2.25029036 |
| 107 | Cardiovascular calcification (HP:0011915) | 2.24763238 |
| 108 | Abnormal gallbladder morphology (HP:0012437) | 2.24517029 |
| 109 | Exertional dyspnea (HP:0002875) | 2.24189850 |
| 110 | Abnormality of macrophages (HP:0004311) | 2.23252773 |
| 111 | Rib fusion (HP:0000902) | 2.22467426 |
| 112 | Tinnitus (HP:0000360) | 2.22217939 |
| 113 | Retrobulbar optic neuritis (HP:0100654) | 2.22024705 |
| 114 | Optic neuritis (HP:0100653) | 2.22024705 |
| 115 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.21438674 |
| 116 | Hypoglycemic seizures (HP:0002173) | 2.18898668 |
| 117 | Thrombophlebitis (HP:0004418) | 2.18544556 |
| 118 | Cholelithiasis (HP:0001081) | 2.18366995 |
| 119 | Hydroxyprolinuria (HP:0003080) | 2.17318765 |
| 120 | Abnormality of proline metabolism (HP:0010907) | 2.17318765 |
| 121 | Increased serum lactate (HP:0002151) | 2.16964767 |
| 122 | Increased intramyocellular lipid droplets (HP:0012240) | 2.15480878 |
| 123 | Pancreatitis (HP:0001733) | 2.12009785 |
| 124 | Homocystinuria (HP:0002156) | 2.11543620 |
| 125 | Abnormality of homocysteine metabolism (HP:0010919) | 2.11543620 |
| 126 | Neonatal onset (HP:0003623) | 2.10635083 |
| 127 | Vomiting (HP:0002013) | 2.10203589 |
| 128 | Abnormality of iron homeostasis (HP:0011031) | 2.10089022 |
| 129 | Proximal tubulopathy (HP:0000114) | 2.08611707 |
| 130 | Gout (HP:0001997) | 2.07908435 |
| 131 | Opisthotonus (HP:0002179) | 2.04885316 |
| 132 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.04286908 |
| 133 | Irritability (HP:0000737) | 2.03418801 |
| 134 | Hypoplasia of the pons (HP:0012110) | 2.02184962 |
| 135 | Epistaxis (HP:0000421) | 2.02004435 |
| 136 | Hemorrhage of the eye (HP:0011885) | 2.01449123 |
| 137 | Premature graying of hair (HP:0002216) | 2.01223941 |
| 138 | Malnutrition (HP:0004395) | 2.00816234 |
| 139 | Abnormal gallbladder physiology (HP:0012438) | 2.00743555 |
| 140 | Cholecystitis (HP:0001082) | 2.00743555 |
| 141 | Abnormal cartilage morphology (HP:0002763) | 2.00723578 |
| 142 | Sensorimotor neuropathy (HP:0007141) | 1.99205284 |
| 143 | Brushfield spots (HP:0001088) | 1.97662553 |
| 144 | Progressive macrocephaly (HP:0004481) | 1.97055253 |
| 145 | Lactic acidosis (HP:0003128) | 1.96886856 |
| 146 | Amyloidosis (HP:0011034) | 1.96388780 |
| 147 | Abnormality of the pons (HP:0007361) | 1.95873162 |
| 148 | Enlarged kidneys (HP:0000105) | 1.94888719 |
| 149 | Purpura (HP:0000979) | 1.92707955 |
| 150 | Protruding tongue (HP:0010808) | 1.91571439 |
| 151 | Abnormal drinking behavior (HP:0030082) | 1.91294991 |
| 152 | Polydipsia (HP:0001959) | 1.91294991 |
| 153 | Clumsiness (HP:0002312) | 1.91084854 |
| 154 | Poikilocytosis (HP:0004447) | 1.90511620 |
| 155 | Late onset (HP:0003584) | 1.90005336 |
| 156 | Elevated hepatic transaminases (HP:0002910) | 1.89639157 |
| 157 | Nephritis (HP:0000123) | 1.88677315 |
| 158 | Recurrent abscess formation (HP:0002722) | 1.88512876 |
| 159 | Abolished electroretinogram (ERG) (HP:0000550) | 1.86981061 |
| 160 | Paralysis (HP:0003470) | 1.86970420 |
| 161 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.85084544 |
| 162 | Optic disc pallor (HP:0000543) | 1.84830628 |
| 163 | Pancreatic cysts (HP:0001737) | 1.83747654 |
| 164 | Glycosuria (HP:0003076) | 1.82593018 |
| 165 | Abnormality of urine glucose concentration (HP:0011016) | 1.82593018 |
| 166 | Abnormality of the gallbladder (HP:0005264) | 1.82141408 |
| 167 | Rectovaginal fistula (HP:0000143) | 1.81886148 |
| 168 | Rectal fistula (HP:0100590) | 1.81886148 |
| 169 | Respiratory difficulties (HP:0002880) | 1.81454364 |
| 170 | Vaginal fistula (HP:0004320) | 1.81295651 |
| 171 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.81270459 |
| 172 | Recurrent bacterial skin infections (HP:0005406) | 1.80801681 |
| 173 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.80514758 |
| 174 | Reduced antithrombin III activity (HP:0001976) | 1.78561925 |
| 175 | Methylmalonic aciduria (HP:0012120) | 1.76728198 |
| 176 | Macular degeneration (HP:0000608) | 1.74429482 |
| 177 | Abnormality of renal resorption (HP:0011038) | 1.74130155 |
| 178 | Increased serum ferritin (HP:0003281) | 1.73767895 |
| 179 | Ileus (HP:0002595) | 1.73666745 |
| 180 | Bile duct proliferation (HP:0001408) | 1.73400990 |
| 181 | Abnormal biliary tract physiology (HP:0012439) | 1.73400990 |
| 182 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.73285487 |
| 183 | Poikiloderma (HP:0001029) | 1.70263483 |
| 184 | Dysostosis multiplex (HP:0000943) | 1.70025611 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 5.95410971 |
| 2 | ERN1 | 3.88237793 |
| 3 | FGFR4 | 3.43891595 |
| 4 | SIK1 | 3.41659480 |
| 5 | PDK2 | 3.29083765 |
| 6 | RIPK4 | 3.23854858 |
| 7 | TLK1 | 2.82550693 |
| 8 | TAOK3 | 2.69900679 |
| 9 | ADRBK2 | 2.68985707 |
| 10 | INSRR | 2.54453801 |
| 11 | NEK9 | 2.52124996 |
| 12 | PKN2 | 2.51798626 |
| 13 | FLT3 | 2.45946789 |
| 14 | TYK2 | 2.08637441 |
| 15 | WNK4 | 2.07433124 |
| 16 | PIK3CG | 2.03565108 |
| 17 | MST1R | 2.00545248 |
| 18 | MAP3K14 | 1.99012245 |
| 19 | KDR | 1.98374075 |
| 20 | IRAK3 | 1.95571902 |
| 21 | TESK2 | 1.90414625 |
| 22 | FRK | 1.84276062 |
| 23 | ERBB4 | 1.78298884 |
| 24 | EIF2AK1 | 1.75306488 |
| 25 | ABL2 | 1.74713829 |
| 26 | TBK1 | 1.74410874 |
| 27 | BMPR1B | 1.65945872 |
| 28 | TXK | 1.64171373 |
| 29 | MAP2K3 | 1.58419367 |
| 30 | MAPK11 | 1.55695215 |
| 31 | TNK2 | 1.54548836 |
| 32 | ADRBK1 | 1.45403135 |
| 33 | OXSR1 | 1.43056086 |
| 34 | IRAK4 | 1.40801414 |
| 35 | JAK2 | 1.31531065 |
| 36 | JAK1 | 1.30133879 |
| 37 | MAP2K4 | 1.29143583 |
| 38 | TRIB3 | 1.21784028 |
| 39 | BLK | 1.21460003 |
| 40 | PTK6 | 1.20119115 |
| 41 | KIT | 1.18354013 |
| 42 | CAMKK2 | 1.18123975 |
| 43 | TGFBR2 | 1.15945438 |
| 44 | MARK3 | 1.13883804 |
| 45 | GRK7 | 1.12391325 |
| 46 | LATS1 | 1.10305460 |
| 47 | MAPK15 | 1.08951689 |
| 48 | CDK6 | 1.06558761 |
| 49 | GRK1 | 1.03801510 |
| 50 | BUB1 | 1.03569578 |
| 51 | CDK19 | 1.02659796 |
| 52 | CSF1R | 1.02599855 |
| 53 | NME2 | 1.01258839 |
| 54 | DAPK1 | 0.99676792 |
| 55 | PBK | 0.97931862 |
| 56 | SYK | 0.97291845 |
| 57 | PRKAA2 | 0.96502786 |
| 58 | GRK5 | 0.95947792 |
| 59 | MAP3K3 | 0.94457049 |
| 60 | WNK3 | 0.90941656 |
| 61 | EPHA3 | 0.90507357 |
| 62 | EIF2AK3 | 0.88621942 |
| 63 | MATK | 0.88607521 |
| 64 | CSK | 0.88020411 |
| 65 | MAP3K11 | 0.87639854 |
| 66 | NME1 | 0.85825763 |
| 67 | NUAK1 | 0.84150014 |
| 68 | TIE1 | 0.83150544 |
| 69 | MYLK | 0.81530662 |
| 70 | PINK1 | 0.79024008 |
| 71 | IKBKE | 0.77424035 |
| 72 | MAPKAPK3 | 0.77066162 |
| 73 | MAPK4 | 0.76575703 |
| 74 | BTK | 0.76431412 |
| 75 | GRK6 | 0.75696027 |
| 76 | BMPR2 | 0.74730177 |
| 77 | STK38L | 0.73467134 |
| 78 | PHKG1 | 0.68010458 |
| 79 | PHKG2 | 0.68010458 |
| 80 | EIF2AK2 | 0.67650019 |
| 81 | EPHB1 | 0.67582462 |
| 82 | MST4 | 0.67555426 |
| 83 | PDPK1 | 0.67484669 |
| 84 | SIK2 | 0.67057083 |
| 85 | IKBKB | 0.66731024 |
| 86 | PTK2B | 0.64522120 |
| 87 | PAK1 | 0.61791309 |
| 88 | HCK | 0.61672133 |
| 89 | MAP3K7 | 0.61656895 |
| 90 | DYRK1B | 0.61356382 |
| 91 | DAPK2 | 0.61122738 |
| 92 | TEC | 0.60578317 |
| 93 | PIM2 | 0.60267263 |
| 94 | JAK3 | 0.58818525 |
| 95 | MAP2K6 | 0.57624593 |
| 96 | PKN1 | 0.56954876 |
| 97 | RIPK1 | 0.56643524 |
| 98 | IRAK1 | 0.56613034 |
| 99 | RPS6KA5 | 0.56300436 |
| 100 | MAP3K5 | 0.56288208 |
| 101 | ERBB2 | 0.55488186 |
| 102 | PRKACG | 0.55352568 |
| 103 | CAMK1 | 0.54882995 |
| 104 | CDK4 | 0.54839895 |
| 105 | STK3 | 0.53702072 |
| 106 | PRKG2 | 0.51862552 |
| 107 | TRPM7 | 0.51704359 |
| 108 | LYN | 0.50866561 |
| 109 | ZAP70 | 0.49923116 |
| 110 | TTN | 0.49466230 |
| 111 | MAPK13 | 0.49334784 |
| 112 | PDK3 | 0.48795753 |
| 113 | PDK4 | 0.48795753 |
| 114 | MET | 0.48539674 |
| 115 | MAP4K1 | 0.48452342 |
| 116 | IGF1R | 0.48016591 |
| 117 | OBSCN | 0.47227084 |
| 118 | FGFR3 | 0.46366279 |
| 119 | PRKAA1 | 0.46040215 |
| 120 | BMX | 0.45789045 |
| 121 | IRAK2 | 0.45591151 |
| 122 | GSK3A | 0.45397969 |
| 123 | PDK1 | 0.45074123 |
| 124 | TGFBR1 | 0.43972553 |
| 125 | PRKCZ | 0.43861150 |
| 126 | MAP4K2 | 0.43682262 |
| 127 | TAOK2 | 0.43537072 |
| 128 | TNIK | 0.42499312 |
| 129 | NEK2 | 0.42245444 |
| 130 | NTRK3 | 0.41933876 |
| 131 | MAPK12 | 0.40742592 |
| 132 | LRRK2 | 0.39262148 |
| 133 | NEK1 | 0.39031037 |
| 134 | SCYL2 | 0.38807263 |
| 135 | MAP3K10 | 0.38686162 |
| 136 | PRKCQ | 0.37799334 |
| 137 | CAMK1D | 0.37734083 |
| 138 | ACVR1B | 0.37280538 |
| 139 | STK16 | 0.36928227 |
| 140 | STK4 | 0.36598980 |
| 141 | PIM1 | 0.36158875 |
| 142 | MUSK | 0.34967566 |
| 143 | ZAK | 0.34044521 |
| 144 | ABL1 | 0.34037131 |
| 145 | PRKCD | 0.33899359 |
| 146 | DAPK3 | 0.33820552 |
| 147 | RPS6KA4 | 0.33202885 |
| 148 | RAF1 | 0.32544611 |
| 149 | PRKCG | 0.31773596 |
| 150 | BRSK2 | 0.31700791 |
| 151 | LCK | 0.30625524 |
| 152 | WNK1 | 0.29788839 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.34435196 |
| 2 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 3.49626563 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.32857795 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.15051002 |
| 5 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.13095916 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.86814667 |
| 7 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.75638748 |
| 8 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.74949915 |
| 9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.68958670 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.62886468 |
| 11 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.55163776 |
| 12 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.49646802 |
| 13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.47060234 |
| 14 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.45577174 |
| 15 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.37182245 |
| 16 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.36995588 |
| 17 | Peroxisome_Homo sapiens_hsa04146 | 2.16162556 |
| 18 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.09570199 |
| 19 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.02611048 |
| 20 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.01972984 |
| 21 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.01259114 |
| 22 | Histidine metabolism_Homo sapiens_hsa00340 | 1.97112367 |
| 23 | RNA polymerase_Homo sapiens_hsa03020 | 1.97018095 |
| 24 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.93109822 |
| 25 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.91088786 |
| 26 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.90875926 |
| 27 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.90433844 |
| 28 | Parkinsons disease_Homo sapiens_hsa05012 | 1.88458710 |
| 29 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.84547251 |
| 30 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.83074875 |
| 31 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.81166171 |
| 32 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.77680578 |
| 33 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.77245685 |
| 34 | Proteasome_Homo sapiens_hsa03050 | 1.75680238 |
| 35 | Homologous recombination_Homo sapiens_hsa03440 | 1.69627212 |
| 36 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.68779372 |
| 37 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.68046411 |
| 38 | Retinol metabolism_Homo sapiens_hsa00830 | 1.66861577 |
| 39 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.66712735 |
| 40 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.59431909 |
| 41 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.52054807 |
| 42 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.49435915 |
| 43 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.47409424 |
| 44 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.42967379 |
| 45 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.41221347 |
| 46 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.39186440 |
| 47 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.37098061 |
| 48 | Carbon metabolism_Homo sapiens_hsa01200 | 1.29288667 |
| 49 | Bile secretion_Homo sapiens_hsa04976 | 1.27392300 |
| 50 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.26666666 |
| 51 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.25601194 |
| 52 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.22905274 |
| 53 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.22867638 |
| 54 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.21796269 |
| 55 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.20882606 |
| 56 | Alzheimers disease_Homo sapiens_hsa05010 | 1.19949456 |
| 57 | ABC transporters_Homo sapiens_hsa02010 | 1.19767646 |
| 58 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.19228391 |
| 59 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.18874500 |
| 60 | Huntingtons disease_Homo sapiens_hsa05016 | 1.17738589 |
| 61 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.10696120 |
| 62 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.10479105 |
| 63 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.09372720 |
| 64 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.07307812 |
| 65 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.07261362 |
| 66 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.98187908 |
| 67 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.98087020 |
| 68 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.98017054 |
| 69 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.97707106 |
| 70 | Sulfur relay system_Homo sapiens_hsa04122 | 0.94019227 |
| 71 | Nicotine addiction_Homo sapiens_hsa05033 | 0.89809573 |
| 72 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.83737125 |
| 73 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.83656939 |
| 74 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.82516139 |
| 75 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.81886930 |
| 76 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.81218185 |
| 77 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.80591042 |
| 78 | Lysine degradation_Homo sapiens_hsa00310 | 0.78274822 |
| 79 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.76142977 |
| 80 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.75774404 |
| 81 | Phototransduction_Homo sapiens_hsa04744 | 0.74741135 |
| 82 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.73978903 |
| 83 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.73634524 |
| 84 | Purine metabolism_Homo sapiens_hsa00230 | 0.69640081 |
| 85 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.69381838 |
| 86 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.69350582 |
| 87 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.68075795 |
| 88 | Morphine addiction_Homo sapiens_hsa05032 | 0.67790969 |
| 89 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.67566104 |
| 90 | Tuberculosis_Homo sapiens_hsa05152 | 0.66685716 |
| 91 | Olfactory transduction_Homo sapiens_hsa04740 | 0.64124518 |
| 92 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.59637743 |
| 93 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.58766649 |
| 94 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.58118276 |
| 95 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.57986024 |
| 96 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.55576549 |
| 97 | Metabolic pathways_Homo sapiens_hsa01100 | 0.50061356 |
| 98 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.46388583 |
| 99 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.45605303 |
| 100 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.45522281 |
| 101 | Taste transduction_Homo sapiens_hsa04742 | 0.44139017 |
| 102 | Mismatch repair_Homo sapiens_hsa03430 | 0.44133553 |
| 103 | Mineral absorption_Homo sapiens_hsa04978 | 0.44107237 |
| 104 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.42122458 |
| 105 | Galactose metabolism_Homo sapiens_hsa00052 | 0.41265729 |
| 106 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.39969547 |
| 107 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.35496021 |
| 108 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.27112491 |
| 109 | Insulin resistance_Homo sapiens_hsa04931 | 0.26677415 |
| 110 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.22720500 |
| 111 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.18972242 |
| 112 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.17106030 |
| 113 | Prion diseases_Homo sapiens_hsa05020 | 0.17002489 |
| 114 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.16624996 |
| 115 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.11318597 |
| 116 | Legionellosis_Homo sapiens_hsa05134 | 0.05621033 |
| 117 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.02952177 |
| 118 | Pertussis_Homo sapiens_hsa05133 | 0.02483743 |
| 119 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1321295 |
| 120 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1208606 |
| 121 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | -0.1186821 |
| 122 | Hepatitis C_Homo sapiens_hsa05160 | -0.1163867 |
| 123 | Leishmaniasis_Homo sapiens_hsa05140 | -0.1160243 |
| 124 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | -0.1087015 |
| 125 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1057386 |
| 126 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1002836 |
| 127 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.0942248 |
| 128 | Malaria_Homo sapiens_hsa05144 | -0.0891006 |
| 129 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | -0.0885151 |
| 130 | Pyrimidine metabolism_Homo sapiens_hsa00240 | -0.0672324 |
| 131 | Lysosome_Homo sapiens_hsa04142 | -0.0652278 |
| 132 | Other glycan degradation_Homo sapiens_hsa00511 | -0.0549688 |
| 133 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0448022 |
| 134 | Glucagon signaling pathway_Homo sapiens_hsa04922 | -0.0264732 |
| 135 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0226074 |
| 136 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0222563 |
| 137 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | -0.0089189 |

